Chronic News and Research

RSS

Breakthrough antibiotic targets gum disease without harming microbiome

The ADA Forsyth Institute, a leading oral health research organization, and Flightpath Biosciences Inc. are excited to announce a groundbreaking discovery in the fight against severe gum disease and related systemic conditions.

4 Sep 2024

Study explores the effects of hyperosmotic stress on microglial cells

Microglia are the brain's immune cells known to play a vital role in maintaining neural function and responding to potential threats.

4 Sep 2024

Regular mobile phone use linked to increased cardiovascular disease risk in smokers and diabetics

A new study has found that regular mobile phone use was positively associated with incident cardiovascular diseases risk, especially in current smokers and individuals with diabetes. In addition, this association was partly attributed to poor sleep, psychological distress, and neuroticism.

4 Sep 2024

Does air pollution drive dementia?

Chronic air pollution exposure is a key factor in dementia development, with pollutants like PM2.5 and NO2 linked to cognitive decline and neurodegeneration.

4 Sep 2024

Gut bacteria pathways directly linked to insomnia risk identified

Study uncovers a causal link between specific gut microbiome metabolic pathways and insomnia, highlighting potential therapeutic targets for improving sleep quality.

3 Sep 2024

New computational tool accurately assesses health through gut microbiome analysis

A team of Mayo Clinic researchers has developed an innovative computational tool that analyzes the gut microbiome, a complex ecosystem of trillions of bacteria, fungi, viruses and other microorganisms within the digestive system, to provide insights into overall well-being.

3 Sep 2024

Penn research uncovers key biomarker for diagnosing sarcoidosis

Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin disease.

3 Sep 2024

Dietary habits or gastrointestinal disease associated with the development of belching disorders

Belching is a common bodily function, but when it escalates to a level that interferes with daily life, it is defined as belching disorders.

3 Sep 2024

Study links higher hair cortisol levels to greater behavioral problems in children

In a study within the INMA project and involving 11-year-olds, Ane Arregi, a member of the Basque Environmental Health Research Group of the University of the Basque Country (UPV/EHU), has concluded that greater behavioral problems are linked to higher hair cortisol levels.

3 Sep 2024

Hormonal treatment could delay biological aging among postmenopausal females

Hormone treatment in postmenopausal women is associated with lower biological aging discrepancies, particularly among those with lower socioeconomic status.

3 Sep 2024

European Society of Cardiology highlights underrecognized link between obesity and heart disease

Obesity is a key factor in cardiovascular disease, prompting the ESC to recommend comprehensive strategies for prevention and management to reduce health risks.

3 Sep 2024

$FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction$

FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction

Finerenone reduced heart failure (HF) events and cardiovascular death in patients with HF and mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Different types and sources of carbohydrate found to be protective against gout

The study found that carbohydrates prevent gout, whereas free sugars have the opposite impact.

2 Sep 2024

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Tirzepatide, a once-weekly dual agonist, outperforms long-acting insulin in reducing HbA1c, body weight, and improving cardiovascular markers in Type 2 diabetes patients.

2 Sep 2024

Fermented lingonberry juice shown to reduce inflammation and support gut health in IBD

Fermented lingonberry juice may help manage inflammatory bowel disease (IBD) by modulating both the oral and gut microbiomes, reducing inflammation, and promoting beneficial bacteria.

2 Sep 2024

Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation (AF) and stable coronary artery disease (CAD), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.

1 Sep 2024

American football head impacts tied to increased brain damage and cognitive decline

Repetitive head impacts in former American football players are linked to increased perivascular space volume, which correlates with cognitive decline and neurodegeneration. The study suggests that the force of head impacts may be more critical than frequency, with potential protective effects from β-blocker use.

1 Sep 2024

Interrupting beta-blockers after myocardial infarction shows no advantage

The cardiovascular safety of interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI) and there was no benefit to the patients' quality of life, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

30 Aug 2024

Chronic News and Research

Breakthrough antibiotic targets gum disease without harming microbiome

Study explores the effects of hyperosmotic stress on microglial cells

Regular mobile phone use linked to increased cardiovascular disease risk in smokers and diabetics

Does air pollution drive dementia?

Gut bacteria pathways directly linked to insomnia risk identified

New computational tool accurately assesses health through gut microbiome analysis

Penn research uncovers key biomarker for diagnosing sarcoidosis

Dietary habits or gastrointestinal disease associated with the development of belching disorders

Study links higher hair cortisol levels to greater behavioral problems in children

Hormonal treatment could delay biological aging among postmenopausal females

European Society of Cardiology highlights underrecognized link between obesity and heart disease

FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

Different types and sources of carbohydrate found to be protective against gout

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Fermented lingonberry juice shown to reduce inflammation and support gut health in IBD

Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

American football head impacts tied to increased brain damage and cognitive decline

Interrupting beta-blockers after myocardial infarction shows no advantage

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News